Literature DB >> 7046453

Fibrin deposits in Hodgkin's disease.

N L Harris, A M Dvorak, J Smith, H F Dvorak.   

Abstract

Fibrin deposits were observed in the involved lymph nodes and/or spleens of 15 patients with Hodgkin's disease by specific immunofluorescence and by electron microscopy. Two basic patterns of fibrin deposition were observed: 1) intercellular deposits, chiefly associated with nonneoplastic-appearing lymphoid cells and 2) deposits associated with the collagen fibers of young connective tissue. In addition, coarse fibrin deposits were observed in areas of necrosis, presumably a non-specific finding. Fibronectin was also observed in intercellular areas, but staining was less intense than for fibrin. Fibrin deposits were also observed in 3 of 6 cases of non-Hodgkin's lymphoma, indicating that the finding is not an exclusive feature of Hodgkin's disease. The pathogenesis and possible significance of fibrin deposition in Hodgkin's disease are related to earlier observations of activation of the coagulation system on neoplasia and cell-mediated immunity and to the possible role of fibrin, fibronectin, and their breakdown products in angiogenesis and fibroplasia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046453      PMCID: PMC1916024     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Proteinaceous precipitate in nodular (follicular) lymphomas.

Authors:  A Rosas-Uribe; D Variakojis; H Rappaport
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

2.  Thromboplastic and fibrinolytic properties of three transplantable rat tumours.

Authors:  H I Peterson; L Zettergren
Journal:  Acta Chir Scand       Date:  1970

3.  Follicular lymphoma with deposits of amorphous hyaline material.

Authors:  A Talerman; H P Platenburg
Journal:  J Pathol       Date:  1974-01       Impact factor: 7.996

4.  Intrafollicular hyalinosis and arterial hyalinosis of the spleen: histochemical and immunofluorescence studies.

Authors:  J H Cooper; B M Haq; H Bagnell
Journal:  J Pathol       Date:  1969-07       Impact factor: 7.996

5.  Ultrastructural studies of Hodgkin's disease.

Authors:  R F Dorfman; D F Rice; A D Mitchell; R L Kempson; G Levine
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

6.  Tumor thromboplastic activity in vitro.

Authors:  E D Holyoke; A L Frank; L Weiss
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

7.  Novel human serum protein from fibroblast plasma membrane.

Authors:  E Ruoslahti; A Vaheri
Journal:  Nature       Date:  1974-04-26       Impact factor: 49.962

8.  131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials.

Authors:  I L Spar; W F Bale; D Marrack; W C Dewey; R J McCardle; P V Harper
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

9.  The pathology and nomenclature of Hodgkin's disease.

Authors:  R J Lukes; J J Butler
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

10.  Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man.

Authors:  R B Colvin; R A Johnson; M C Mihm; H F Dvorak
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  8 in total

1.  Morphological and immunohistochemical studies of Hodgkin's disease in the spleen.

Authors:  M Takeshita; S Falk; J Schwetje; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  The distribution of fibronectin in lymph nodes infiltrated by Hodgkin's disease. An immunoperoxidase study on paraffin sections.

Authors:  P Möller; H Achtsätter; M Butzengeiger; B Schüle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

3.  Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma.

Authors:  L F Brown; L Van de Water; V S Harvey; H F Dvorak
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

Review 4.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Regulation of fibrin deposition by malignant mesothelioma.

Authors:  S Idell; S Pueblitz; S Emri; Y Gungen; L Gray; A Kumar; D Holiday; K B Koenig; A R Johnson
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

6.  Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma.

Authors:  Justin P Chan; Mario Merlini; Hua-Xin Gao; Andrew S Mendiola; Katerina Akassoglou; James L Rubenstein; Jae Kyu Ryu
Journal:  Am J Pathol       Date:  2021-03       Impact factor: 4.307

7.  Characterization of factor XIII containing-macrophages in lymph nodes with Hodgkin's disease.

Authors:  R Adány; Z Nemes; L Muszbek
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

8.  Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells.

Authors:  S Atagi; S Sone; K Fukuta; T Ogura
Journal:  Jpn J Cancer Res       Date:  1992-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.